LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+11.42%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.25B
AUM Growth
+$1.25B
(+6.1%)
Cap. Flow
+$6.76M
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
377
New
103
Increased
165
Reduced
63
Closed
19
Top Buys
| 1 |
InMode
INMD
|
$18.4M |
| 2 |
Merck
MRK
|
$18M |
| 3 |
KE Holdings
BEKE
|
$13.9M |
| 4 |
Huazhu Hotels Group
HTHT
|
$11.3M |
| 5 |
Insulet
PODD
|
$11.2M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$38.6M |
| 2 |
iShares MSCI EAFE Value ETF
EFV
|
$33.9M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
$33.7M |
| 4 |
AbbVie
ABBV
|
$18.6M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
$12.5M |
Sector Composition
| 1 | Healthcare | 45.52% |
| 2 | Financials | 14.68% |
| 3 | Consumer Discretionary | 13.33% |
| 4 | Technology | 10.6% |
| 5 | Industrials | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
PepsiCo
PEP
$203B
| $2.62M | 0.21% |
14,484
-5,222
| -26% | -$943K |
|
102
JPMorgan Chase
JPM
$824B
| $2.54M | 0.2% |
18,975
+3,638
| +24% | +$488K |
|
103
Guardant Health
GH
$8.11B
| $2.54M | 0.2% |
93,495
+73,454
| +367% | +$2M |
|
104
Alexandria Real Estate Equities
ARE
$13.9B
| $2.49M | 0.2% |
17,062
-7,764
| -31% | -$1.13M |
|
105
Teladoc Health
TDOC
$1.37B
| $2.48M | 0.2% |
104,900
-6,920
| -6% | -$164K |
|
|
ITCI
106
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.46M | 0.2% |
+46,449
| New | +$2.46M |
|
107
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.46B
| $2.44M | 0.19% |
84,126
-58,664
| -41% | -$1.7M |
|
108
Exxon Mobil
XOM
$477B
| $2.42M | 0.19% |
21,982
+1,490
| +7% | +$164K |
|
|
AZPN
109
DELISTED
Aspen Technology Inc
AZPN
| $2.42M | 0.19% |
11,779
-5,117
| -30% | -$1.05M |
|
110
Coca-Cola
KO
$297B
| $2.33M | 0.19% |
36,704
-23,853
| -39% | -$1.52M |
|
|
111
AbbVie
ABBV
$374B
| $2.33M | 0.19% |
14,397
-115,331
| -89% | -$18.6M |
|
112
Zoetis
ZTS
$67.6B
| $2.27M | 0.18% |
+15,465
| New | +$2.27M |
|
113
Kura Oncology
KURA
$732M
| $2.24M | 0.18% |
180,500
-37,866
| -17% | -$470K |
|
114
Procter & Gamble
PG
$370B
| $2.16M | 0.17% |
14,222
-10,503
| -42% | -$1.59M |
|
115
Editas Medicine
EDIT
$225M
| $2.15M | 0.17% |
242,248
| – | – |
|
116
Enphase Energy
ENPH
$4.85B
| $2.15M | 0.17% |
8,104
+589
| +8% | +$156K |
|
117
Intellia Therapeutics
NTLA
$1.26B
| $2.13M | 0.17% |
61,004
| – | – |
|
118
Iovance Biotherapeutics
IOVA
$800M
| $2.1M | 0.17% |
327,926
| – | – |
|
119
Mercado Libre
MELI
$120B
| $2.07M | 0.17% |
2,452
+201
| +9% | +$170K |
|
120
Vanguard Total World Stock ETF
VT
$51.4B
| $2.05M | 0.16% |
23,820
| – | – |
|
121
Home Depot
HD
$406B
| $2M | 0.16% |
6,329
+223
| +4% | +$70.4K |
|
122
Danaher
DHR
$143B
| $2M | 0.16% |
7,526
-378
| -5% | -$100K |
|
123
Trex
TREX
$6.41B
| $1.95M | 0.16% |
46,008
| – | – |
|
124
Mastercard
MA
$536B
| $1.91M | 0.15% |
5,491
+1,126
| +26% | +$392K |
|
125
Sangamo Therapeutics
SGMO
$161M
| $1.91M | 0.15% |
607,760
-74,540
| -11% | -$234K |
|